课题基金 / 基金详情

Tools to evaluate POP2 as a regulator of arthritis

Tools to evaluate POP2 as a regulator of arthritis
评估 POP2 作为关节炎调节剂的工具
批准号:
9979151
负责人:
JONATHAN A HARTON
金额:
$8.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2022-02-28

项目摘要

项目成果

JONATHAN A HARTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Inflammation underlies the disabling manifestations and co-morbidities of rheumatoid arthritis (RA). Genetic differences in the regulation of inflammatory signaling between individuals are highly relevant and significant as such differences likely determine those individuals that will progress to RA, the severity of their disease, and even influence the treatment options that will be palliative. Much of our understanding of the pathophysiology of RA is based in part on animal models. However, recent work demonstrates that humans posses seven genes coding Pyrin-only and CARD-only proteins (POPs and COPs) that limit NF-kB signaling and infammasome activation pathways, events critical for elaboration of the cytokines mediating inflammation. We have identified an allele of POP2 associated with severe, and likely treatment resistant RA. Evaluating the function of this RA-associated allele in vivo and in vitro will help reveal the immunological and molecular basis for the association and provide insight into why some RA patients develop severe RA resistant to otherwise effective treatment with sophisticated biologics targeting TNF and IL-6. Such knowledge could help guide clinical decision making and advance efforts to identify new therapeutic modalities. This application proposes a transgenic mouse model and cellular tools to investigate the nature of the POP2 allele associated with RA. These tools are a necessary first step towards further investigation of the function of POP2 in RA disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POP2 as a novel therapeutic in rheumatoid arthritis
  • 批准号:
    10709887
  • 项目类别:
  • 资助金额:
    $17.93万
  • 财政年份:
    2022
  • 负责人:
    JONATHAN A HARTON
  • 依托单位:
POP2 as a novel therapeutic in rheumatoid arthritis
  • 批准号:
    10524468
  • 项目类别:
  • 资助金额:
    $21.52万
  • 财政年份:
    2022
  • 负责人:
    JONATHAN A HARTON
  • 依托单位:
Tools to evaluate POP2 as a regulator of arthritis
  • 批准号:
    10116275
  • 项目类别:
  • 资助金额:
    $8.15万
  • 财政年份:
    2020
  • 负责人:
    JONATHAN A HARTON
  • 依托单位:
Regulation of Innate Immunity by Pyrin Proteins
  • 批准号:
    7736107
  • 项目类别:
  • 资助金额:
    $36.5万
  • 财政年份:
    2009
  • 负责人:
    JONATHAN A HARTON
  • 依托单位:
海外基金